GlaxoSmithKline plc (GSK)
-NYSE 51.43 
0.07(0.14%) 4:01PM EDT
| Prev Close: | 51.50 |
|---|
| Open: | 51.32 |
|---|
| Bid: | 51.43 x 100 |
|---|
| Ask: | 51.74 x 200 |
|---|
| 1y Target Est: | 47.56 |
|---|
| Beta: | 0.55 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 51.27 - 51.61 |
|---|
| 52wk Range: | 41.68 - 52.54 |
|---|
| Volume: | 1,894,241 |
|---|
| Avg Vol (3m): | 2,854,820 |
|---|
| Market Cap: | 124.56B |
|---|
| P/E (ttm): | 18.80 |
|---|
| EPS (ttm): | 2.74 |
|---|
| Div & Yield: | 2.76 (5.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Glaxo's Trametinib DelayedZacks(Thu 4:30PM EDT)
- Athersys Has Some Promise, But Controversy And Doubt Remainat Seeking Alpha(Thu 4:06PM EDT)
- Opko Health CEO Buys 45K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Thu 9:16AM EDT)
- Impax Beats Earnings EstimateZacks(Thu 8:50AM EDT)
- 3 Pharma Stocks to Buy for the Long Runat Motley Fool(Thu 8:28AM EDT)
- The Morning Download: Pharma Trialed Big Brother Techat The Wall Street Journal(Thu 8:04AM EDT)
- Take 2 Dividend Stocks and Call Me in the Morningat Motley Fool(Wed, May 1)
- Glaxo Mined Online Parent Discussion Boards For Vaccine Worriesat The Wall Street Journal(Wed, May 1)
- Why America Is Suing This Pharmaceutical Behemothat Motley Fool(Wed, May 1)
- Big Pharma's Kickback Conundrumat Motley Fool(Wed, May 1)
- Four Companies that Are Better to Invest in Than Amazonat Motley Fool(Wed, May 1)
- 3 Buy-Rated Dividend Stocksat TheStreet(Wed, May 1)
- Is All Well With These 4 Pharmaceutical Powerhouses?at Motley Fool(Wed, May 1)
- Merck Softens A Lower 2013 Profit Forecast With $15B Stock Buybackat Forbes(Wed, May 1)
- Is GlaxoSmithKline an Exciting Emerging Market Play?at Motley Fool(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 15.54 |
|---|
| P/S (ttm): | 2.95 |
|---|
| Ex-Dividend Date: | 20-Feb-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.06 |
|---|
| Quarterly EPS Est
(Mar-13)
: | N/A |
|---|
| Mean Recommendation*: | 2.9 |
|---|
| PEG Ratio (5 yr expected): | 5.33 |
|---|
Business Summary
GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide.
View More